Early autologous stem cell transplantation for poor-risk Chronic Lymphocytic Leukemia (CLL): prognostic factors for feasibility and molecular outcome

被引：0
|
作者：
Dreger, P
von Neuhoff, N
Wittkowsky, G
Sonnen, R
Seyfarth, B
Kuse, R
Glass, B
Schmitz, N
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [1] Efficacy and prognostic implications of early autologous stem cell transplantation for poor-risk chronic lymphocytic leukemia (CLL).
    Dreger, P
    von Neuhoff, N
    Sonnen, R
    Kuse, R
    Seyfarth, B
    Lorenz, G
    Glass, B
    Schmitz, N
    [J]. BLOOD, 2000, 96 (11) : 483A - 483A
  • [2] Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
    Gribben, JG
    Zahrieh, D
    Stephans, K
    Bartlett-Pandite, L
    Alyea, EP
    Fisher, DC
    Freedman, AS
    Mauch, P
    Schlossman, R
    Sequist, LV
    Soiffer, RJ
    Marshall, B
    Neuberg, D
    Ritz, J
    Nadler, LM
    [J]. BLOOD, 2005, 106 (13) : 4389 - 4396
  • [3] Stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL):: Outcome and prognostic factors after autologous and allogeneic transplants.
    Esteve, J
    Montserrat, E
    Dreger, P
    Meloni, G
    Pavletic, S
    Catovsky, D
    Dearden, C
    Scimè, R
    Sutton, L
    Michallet, M
    Desablens, B
    Kimby, E
    Coiffier, B
    Brunet, S
    Sanz, MA
    Besalduch, J
    Caballero, D
    Juliusson, G
    Conde, E
    del Potro, E
    Schmitz, N
    [J]. BLOOD, 2001, 98 (11) : 482A - 482A
  • [4] Analysis of prognostic factors on the outcome of autologous and allogeneic stem cell transplantations (SCT) for chronic lymphocytic leukemia (CLL).
    Michallet, M
    Brand, R
    Dreger, P
    Millighan, D
    Esteve, J
    Kimby, E
    Nicolini, F
    Apperley, J
    van Biezen, A
    Niederwieser, D
    [J]. BLOOD, 2001, 98 (11) : 859A - 860A
  • [5] Prognostic Factors for Outcome of Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Final Results from a Prospective Multicenter Trial (GCLLSG CLL3X study)
    Dreger, Peter
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Ritgen, Matthias
    Dietrich, Sascha
    Bunjes, Donald
    Beelen, Dietrich Wilhelm
    Cohen, Sandra
    Hegenbart, Ute
    Schubert, Joerg
    Stadler, Michael
    Glass, Bertram
    Burchert, Andreas
    Uharek, Lutz
    Hallek, Michael
    Kneba, Michael
    Schmitz, Norbert
    Doehner, Hartmut
    [J]. BLOOD, 2008, 112 (11) : 212 - 212
  • [6] Prognostic factors for survival after autologous stem cell transplantation for chronic lymphocytic leukemia (CLL): The EBMT experience.
    Dreger, P
    van Biezen, A
    Brand, R
    Esteve, J
    Gratwohl, A
    Kimby, E
    Michallet, M
    Milligan, DW
    Niederwieser, D
    [J]. BLOOD, 2000, 96 (11) : 482A - 482A
  • [7] Prognostic factors for survival after autologous and allogeneic stem cell transplantation for Chronic Lymphocytic Leukemia (CLL): The EBMT experience
    Michallet, M
    Brand, R
    Dreger, P
    Milligan, DW
    Esteve, J
    Kimby, E
    Gratwohl, A
    Apperley, J
    Van Biezen, A
    Niederwieser, D
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S31 - S31
  • [8] Early autologous stem cell transplantation (SCT) in genetically poor-risk chronic lymphocytic leukemia is feasible and effective: Results from a prospective multicenter study (GCLLSG CLL3 protocol).
    Dreger, P
    Busch, R
    Stilgenbauer, S
    Greinix, H
    Hensel, M
    Hertenstein, B
    Duehrsen, U
    Hentrich, M
    Truemper, LH
    Schmitz, N
    Ritgen, M
    Emmerich, B
    Hallek, MJ
    Kneba, M
    Dohner, H
    [J]. BLOOD, 2004, 104 (11) : 45A - 45A
  • [9] Feasibility of autologous stem cell transplantation in patients (pts) with advanced B-cell chronic lymphocytic leukemia (CLL).
    Sutton, L
    Maloum, K
    Boccaccio, C
    Albin, N
    Manighetti, J
    Cosset, JM
    Binet, JL
    Leblond, V
    [J]. BLOOD, 1996, 88 (10) : 3614 - 3614
  • [10] Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q-in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial
    Dreger, Peter
    Doehner, Hartmut
    Greinix, Hildegard
    McClanahan, Fabienne
    Hensel, Manfred
    Hertenstein, Bernd
    Duehrsen, Ulrich
    Hentrich, Markus
    Truemper, Lorenz
    Sonnen, Ruth
    Ernmerich, Bertold
    Knauf, Wolfgang Ulrich
    Hopfinger, Georg
    Hallek, Michael
    Kneba, Michael
    Schmitz, Norbert
    Stilgenbauer, Stephan
    [J]. BLOOD, 2009, 114 (22) : 362 - 362
12345